Payment overview · 2025
General Payments
$30.05
1 reported records · 1 companies
Healthcare provider profile · identity verified
Nadezhda Solovyeva, AGACNP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care · NEW YORK, NY · NPI 1053928747
Verified facts
What the public records show
CMS Open Payments records show Nadezhda Solovyeva, AGACNP received $30.05 in general payments during 2025 across 1 reported records.
SK Life Science, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| SK Life Science, Inc. |
SK Life Science, Inc. exact · evidence 2025-04-03 |
$30.05 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $30.05 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| XCOPRI Normalized: xcopri |
Drug | SK Life Science, Inc. | $30.05 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 791 | 82 |
| Atorvastatin Calcium | Atorvastatin Calcium | 663 | 89 |
| Furosemide | Furosemide | 639 | 70 |
| Eliquis | Apixaban | 572 | 64 |
| Pantoprazole Sodium | Pantoprazole Sodium | 557 | 66 |
| Levothyroxine Sodium | Levothyroxine Sodium | 508 | 54 |
| Mirtazapine | Mirtazapine | 466 | 64 |
| Metoprolol Succinate | Metoprolol Succinate | 455 | 57 |
| Metformin Hcl | Metformin Hcl | 436 | 42 |
| Tamsulosin Hcl | Tamsulosin Hcl | 435 | 56 |
| Metoprolol Tartrate | Metoprolol Tartrate | 377 | 43 |
| Omeprazole | Omeprazole | 372 | 42 |
| Gabapentin | Gabapentin | 360 | 39 |
| Potassium Chloride | Potassium Chloride | 327 | 34 |
| Sertraline Hcl | Sertraline Hcl | 305 | 43 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 302 | 33 |
| Losartan Potassium | Losartan Potassium | 291 | 32 |
| Finasteride | Finasteride | 284 | 32 |
| Levetiracetam | Levetiracetam | 213 | 21 |
| Famotidine | Famotidine | 196 | 27 |
| Lisinopril | Lisinopril | 195 | 23 |
| Memantine Hcl | Memantine Hcl | 176 | 15 |
| Hydralazine Hcl | Hydralazine Hcl | 163 | 21 |
| Donepezil Hcl | Donepezil Hcl | 156 | 21 |
| Clopidogrel | Clopidogrel Bisulfate | 153 | 17 |
| Trazodone Hcl | Trazodone Hcl | 146 | 18 |
| Risperidone | Risperidone | 145 | 12 |
| Metformin Hcl Er | Metformin Hcl | 140 | 15 |
| Methenamine Hippurate | Methenamine Hippurate | 140 | 18 |
| Januvia | Sitagliptin Phosphate | 139 | 18 |
| Enalapril Maleate | Enalapril Maleate | 119 | 16 |
| Admelog Solostar | Insulin Lispro | 117 | 30 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 113 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 113 | 15 |
| Montelukast Sodium | Montelukast Sodium | 112 | 14 |
| Escitalopram Oxalate | Escitalopram Oxalate | 98 | suppressed |
| Allopurinol | Allopurinol | 95 | suppressed |
| Nystatin | Nystatin | 88 | 27 |
| Divalproex Sodium | Divalproex Sodium | 87 | suppressed |
| Tradjenta | Linagliptin | 86 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 85 | suppressed |
| Carvedilol | Carvedilol | 81 | 17 |
| Hydrochlorothiazide | Hydrochlorothiazide | 79 | suppressed |
| Jardiance | Empagliflozin | 78 | 11 |
| Entresto | Sacubitril/Valsartan | 77 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 77 | 24 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 76 | 21 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 73 | 15 |
| Simvastatin | Simvastatin | 73 | 17 |
| Silodosin | Silodosin | 70 | suppressed |
| Glipizide | Glipizide | 67 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 67 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 66 | 13 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 62 | 12 |
| Labetalol Hcl | Labetalol Hcl | 60 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 56 | suppressed |
| Atenolol | Atenolol | 56 | suppressed |
| Baclofen | Baclofen | 55 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 54 | suppressed |
| Colchicine | Colchicine | 54 | suppressed |
| Latanoprost | Latanoprost | 54 | 13 |
| Benztropine Mesylate | Benztropine Mesylate | 53 | suppressed |
| Digoxin | Digoxin | 53 | suppressed |
| Glipizide Er | Glipizide | 53 | suppressed |
| Lactulose | Lactulose | 53 | 11 |
| Xarelto | Rivaroxaban | 51 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 50 | 19 |
| Cinacalcet Hcl | Cinacalcet Hcl | 49 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 49 | 14 |
| Sucralfate | Sucralfate | 49 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 47 | suppressed |
| Linzess | Linaclotide | 46 | 15 |
| Oxycodone Hcl | Oxycodone Hcl | 44 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 43 | 11 |
| Vascepa | Icosapent Ethyl | 43 | suppressed |
| Konvomep | Omeprazole/Sodium Bicarbonate | 40 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 38 | suppressed |
| Olanzapine | Olanzapine | 37 | suppressed |
| Nystop | Nystatin | 36 | 12 |
| Sodium Chloride | 0.9 % Sodium Chloride | 36 | 12 |
| Calcitriol | Calcitriol | 35 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 35 | suppressed |
| Erythromycin | Erythromycin Base | 34 | suppressed |
| Spironolactone | Spironolactone | 34 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 34 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 33 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 33 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 33 | 12 |
| Santyl | Collagenase Clostridium Hist. | 33 | suppressed |
| Bupropion Xl | Bupropion Hcl | 32 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 32 | 25 |
| Prednisone | Prednisone | 32 | suppressed |
| Rexulti | Brexpiprazole | 32 | suppressed |
| Glimepiride | Glimepiride | 31 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 29 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 27 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 27 | suppressed |
| Metolazone | Metolazone | 27 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 27 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 27 | suppressed |
| Aripiprazole | Aripiprazole | 26 | suppressed |
| Chlorthalidone | Chlorthalidone | 26 | suppressed |
| Nifedipine Er | Nifedipine | 26 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 25 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 25 | suppressed |
| Timolol Maleate | Timolol Maleate | 25 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 25 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 25 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 24 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 23 | suppressed |
| Alogliptin | Alogliptin Benzoate | 23 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 23 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 23 | suppressed |
| Repaglinide | Repaglinide | 23 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 22 | suppressed |
| Budesonide | Budesonide | 22 | suppressed |
| Dutasteride | Dutasteride | 22 | suppressed |
| Halobetasol Propionate | Halobetasol Propionate | 22 | 11 |
| Lorazepam | Lorazepam | 22 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 22 | suppressed |
| Ursodiol | Ursodiol | 22 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 21 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 21 | suppressed |
| Lamotrigine | Lamotrigine | 21 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 21 | suppressed |
| Mupirocin | Mupirocin | 21 | 12 |
| Novolog Flexpen | Insulin Aspart | 21 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 21 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 21 | suppressed |
| Xtandi | Enzalutamide | 21 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 19 | suppressed |
| Ozempic | Semaglutide | 19 | suppressed |
| Amantadine | Amantadine Hcl | 18 | suppressed |
| Austedo | Deutetrabenazine | 18 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 18 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 18 | suppressed |
| Cefdinir | Cefdinir | 18 | 16 |
| Ezetimibe | Ezetimibe | 18 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 18 | suppressed |
| Brilinta | Ticagrelor | 17 | suppressed |
| Clotrimazole | Clotrimazole | 17 | suppressed |
| Hydrocortisone | Hydrocortisone | 17 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 17 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 16 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 16 | 11 |
| Dexamethasone | Dexamethasone | 16 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 16 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 16 | suppressed |
| Metronidazole | Metronidazole | 16 | suppressed |
| Perphenazine | Perphenazine | 16 | suppressed |
| Anastrozole | Anastrozole | 15 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 15 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 15 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 15 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 15 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 14 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 14 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 14 | suppressed |
| Ranolazine Er | Ranolazine | 14 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 14 | suppressed |
| Acetylcysteine | Acetylcysteine | 13 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 13 | 11 |
| Enoxaparin Sodium | Enoxaparin Sodium | 13 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Letrozole | Letrozole | 13 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 13 | suppressed |
| Ropinirole Er | Ropinirole Hcl | 13 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Bumetanide | Bumetanide | 12 | suppressed |
| Gemtesa | Vibegron | 12 | suppressed |
| Imiquimod | Imiquimod | 12 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 12 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 12 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 12 | suppressed |
| Pregabalin | Pregabalin | 12 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 11 | suppressed |
| Corlanor | Ivabradine Hcl | 11 | suppressed |
| Entacapone | Entacapone | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Multaq | Dronedarone Hcl | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $30.05 · 1 records | SK Life Science, Inc. | XCOPRI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error